Profile - To The Moon

你好吗007

Posts · 18Posts · 18
Following · 0Following · 0
Followers · 0Followers · 0

- 你好吗007你好吗007
  ·2021-02-22
  !
  Sorry, this post has been deleted
  2.86K 3
  3
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-18
  !
  Sorry, this post has been deleted
  3.71K Comment
  2
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-13
  H
  Sorry, this post has been deleted
  2.88K 1
  Like
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-12
  Hdfn
  Sorry, this post has been deleted
  2.45K Comment
  Like
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-10
  !!!
  Sorry, this post has been deleted
  3.63K 1
  2
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-09
  Anazeballs
  Sorry, this post has been deleted
  3.56K 2
  1
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-08
  !!
  Sorry, this post has been deleted
  3.84K Comment
  Like
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-06
  !!!
  U.S. FDA gearing up for rapid review of potential COVID-19 booster shots
  (Reuters) - The U.S. Food and Drug Administration is planning a rapid review process for quick turna
  U.S. FDA gearing up for rapid review of potential COVID-19 booster shots
  4.04K Comment
  Like
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-05
  D
  Sorry, this post has been deleted
  2.35K Comment
  2
  Share
  Report
- 你好吗007你好吗007
  ·2021-02-03
  !!
  Sorry, this post has been deleted
  2.34K Comment
  1
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3567641319219408","uuid":"3567641319219408","gmtCreate":1604553814818,"gmtModify":1733731532967,"name":"你好吗007","pinyin":"nhm007nihaoma007","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":53,"tweetSize":18,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":360483161,"gmtCreate":1613965054653,"gmtModify":1704886234011,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!","listText":"!","text":"!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/360483161","repostId":"1128649853","repostType":4,"isVote":1,"tweetType":1,"viewCount":2855,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384831412,"gmtCreate":1613636843136,"gmtModify":1704882982200,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!","listText":"!","text":"!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384831412","repostId":"1135489805","repostType":4,"isVote":1,"tweetType":1,"viewCount":3706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386251093,"gmtCreate":1613188846112,"gmtModify":1704879334955,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/386251093","repostId":"2110200430","repostType":4,"isVote":1,"tweetType":1,"viewCount":2884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386042417,"gmtCreate":1613120733039,"gmtModify":1704878567250,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"Hdfn","listText":"Hdfn","text":"Hdfn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386042417","repostId":"1179092967","repostType":4,"isVote":1,"tweetType":1,"viewCount":2453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":381679930,"gmtCreate":1612966351620,"gmtModify":1704876633115,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!!!","listText":"!!!","text":"!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/381679930","repostId":"1144142338","repostType":4,"isVote":1,"tweetType":1,"viewCount":3634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":383391754,"gmtCreate":1612835744078,"gmtModify":1704874788755,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"Anazeballs","listText":"Anazeballs","text":"Anazeballs","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/383391754","repostId":"1163750848","repostType":4,"isVote":1,"tweetType":1,"viewCount":3564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389289778,"gmtCreate":1612777653694,"gmtModify":1704874046675,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!!","listText":"!!","text":"!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/389289778","repostId":"1108268363","repostType":4,"isVote":1,"tweetType":1,"viewCount":3836,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380447366,"gmtCreate":1612580940955,"gmtModify":1704873050832,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!!!","listText":"!!!","text":"!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380447366","repostId":"1152247545","repostType":4,"repost":{"id":"1152247545","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612512116,"share":"https://ttm.financial/m/news/1152247545?lang=en_US&edition=fundamental","pubTime":"2021-02-05 16:01","market":"us","language":"en","title":"U.S. FDA gearing up for rapid review of potential COVID-19 booster shots","url":"https://stock-news.laohu8.com/highlight/detail?id=1152247545","media":"Reuters","summary":"(Reuters) - The U.S. Food and Drug Administration is planning a rapid review process for quick turna","content":"<p>(Reuters) - The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency’s top official said on Thursday.</p>\n<p>Dr. Janet Woodcock, acting commissioner of the FDA, said that if new variants of the coronavirus emerge that require booster shots or changes to vaccines, the agency will not require the type of large trials that were required for emergency use authorization or approval.</p>\n<p>The agency plans to issue a proposal on the process for public comment in a few weeks, she said during a press briefing. That process will likely require safety information as well as, if possible, the convening of an outside committee of experts to review the booster shot.</p>\n<p>Both Pfizer Inc and German partner BioNTech SE as well as Moderna Inc, whose vaccines have been authorized for emergency use in the United States, have said they are preparing for the possibility that variants will emerge that could require a booster shot.</p>\n<p>The current vaccines still provide adequate protection against existing variants of concern, Woodcock said. A variant in the U.K. has been found to be more transmissible while some vaccines have been found to be less effective against variants that emerged in South Africa and Brazil.</p>\n<p>Settling on a regulatory process will help the FDA move quickly if needed, she said.</p>\n<p>“If the virus changes, we are getting prepared for that,” Woodcock said.</p>\n<p>The threshold for deciding on whether a new vaccine is needed has not yet been determined. Countries must build surveillance measures to find variants of concerns, and then scientists must agree upon at what point a variant has strayed too far from the unaltered virus and requires a new vaccine.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA gearing up for rapid review of potential COVID-19 booster shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA gearing up for rapid review of potential COVID-19 booster shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-05 16:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency’s top official said on Thursday.</p>\n<p>Dr. Janet Woodcock, acting commissioner of the FDA, said that if new variants of the coronavirus emerge that require booster shots or changes to vaccines, the agency will not require the type of large trials that were required for emergency use authorization or approval.</p>\n<p>The agency plans to issue a proposal on the process for public comment in a few weeks, she said during a press briefing. That process will likely require safety information as well as, if possible, the convening of an outside committee of experts to review the booster shot.</p>\n<p>Both Pfizer Inc and German partner BioNTech SE as well as Moderna Inc, whose vaccines have been authorized for emergency use in the United States, have said they are preparing for the possibility that variants will emerge that could require a booster shot.</p>\n<p>The current vaccines still provide adequate protection against existing variants of concern, Woodcock said. A variant in the U.K. has been found to be more transmissible while some vaccines have been found to be less effective against variants that emerged in South Africa and Brazil.</p>\n<p>Settling on a regulatory process will help the FDA move quickly if needed, she said.</p>\n<p>“If the virus changes, we are getting prepared for that,” Woodcock said.</p>\n<p>The threshold for deciding on whether a new vaccine is needed has not yet been determined. Countries must build surveillance measures to find variants of concerns, and then scientists must agree upon at what point a variant has strayed too far from the unaltered virus and requires a new vaccine.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152247545","content_text":"(Reuters) - The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency’s top official said on Thursday.\nDr. Janet Woodcock, acting commissioner of the FDA, said that if new variants of the coronavirus emerge that require booster shots or changes to vaccines, the agency will not require the type of large trials that were required for emergency use authorization or approval.\nThe agency plans to issue a proposal on the process for public comment in a few weeks, she said during a press briefing. That process will likely require safety information as well as, if possible, the convening of an outside committee of experts to review the booster shot.\nBoth Pfizer Inc and German partner BioNTech SE as well as Moderna Inc, whose vaccines have been authorized for emergency use in the United States, have said they are preparing for the possibility that variants will emerge that could require a booster shot.\nThe current vaccines still provide adequate protection against existing variants of concern, Woodcock said. A variant in the U.K. has been found to be more transmissible while some vaccines have been found to be less effective against variants that emerged in South Africa and Brazil.\nSettling on a regulatory process will help the FDA move quickly if needed, she said.\n“If the virus changes, we are getting prepared for that,” Woodcock said.\nThe threshold for deciding on whether a new vaccine is needed has not yet been determined. Countries must build surveillance measures to find variants of concerns, and then scientists must agree upon at what point a variant has strayed too far from the unaltered virus and requires a new vaccine.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":4040,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317748685,"gmtCreate":1612488881247,"gmtModify":1704871859715,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/317748685","repostId":"2108716497","repostType":4,"isVote":1,"tweetType":1,"viewCount":2351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314179184,"gmtCreate":1612325301248,"gmtModify":1704869748009,"author":{"id":"3567641319219408","authorId":"3567641319219408","name":"你好吗007","avatar":"https://community-static.tradeup.com/news/556ad83347c3b8efc20e4ab7470de465","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567641319219408","idStr":"3567641319219408"},"themes":[],"htmlText":"!!","listText":"!!","text":"!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/314179184","repostId":"2108734055","repostType":4,"isVote":1,"tweetType":1,"viewCount":2337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}